The lipid-lowering drug fenofibrate could be a useful adjunctive treatment for preventing gout in patients with type 2 diabetes, an Australian trial has shown. Use of fenofibrate reduced uric acid levels by 20% and almost halved incident gout events, a retrospective analysis of a trial involving almost 10,000 patients with type 2 diabetes has found. ...
Gout rates halved by lipid-lowering drug
By Michael Woodhead
8 Mar 2018